Illumina Body Map 2
Gene Symbol | Gene ID | Gene Info |
---|---|---|
MEIS2
|
ENSG00000134138.15 | Meis homeobox 2 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
MEIS2 | hg19_v2_chr15_-_37390482_37390572 | -0.87 | 1.4e-10 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr6_-_133084580 | 5.57 |
ENST00000525270.1
ENST00000530536.1 ENST00000524919.1 |
VNN2
|
vanin 2 |
chr7_+_37723450 | 4.95 |
ENST00000447769.1
|
GPR141
|
G protein-coupled receptor 141 |
chr17_-_29648761 | 4.86 |
ENST00000247270.3
ENST00000462804.2 |
EVI2A
|
ecotropic viral integration site 2A |
chr6_-_133084564 | 4.79 |
ENST00000532012.1
|
VNN2
|
vanin 2 |
chr1_-_167487758 | 4.64 |
ENST00000362089.5
|
CD247
|
CD247 molecule |
chr8_-_126963387 | 4.52 |
ENST00000522865.1
ENST00000517869.1 |
LINC00861
|
long intergenic non-protein coding RNA 861 |
chr7_-_142162390 | 4.37 |
ENST00000390371.3
|
TRBV6-6
|
T cell receptor beta variable 6-6 |
chr7_-_142224280 | 4.29 |
ENST00000390367.3
|
TRBV11-1
|
T cell receptor beta variable 11-1 |
chr6_+_42883727 | 4.24 |
ENST00000304672.1
ENST00000441198.1 ENST00000446507.1 |
PTCRA
|
pre T-cell antigen receptor alpha |
chr2_+_204801471 | 4.19 |
ENST00000316386.6
ENST00000435193.1 |
ICOS
|
inducible T-cell co-stimulator |
chr1_-_27961720 | 4.15 |
ENST00000545953.1
ENST00000374005.3 |
FGR
|
feline Gardner-Rasheed sarcoma viral oncogene homolog |
chr14_+_22631122 | 4.13 |
ENST00000390458.3
|
TRAV29DV5
|
T cell receptor alpha variable 29/delta variable 5 (gene/pseudogene) |
chr15_+_81589254 | 4.09 |
ENST00000394652.2
|
IL16
|
interleukin 16 |
chr1_+_158900568 | 4.09 |
ENST00000458222.1
|
PYHIN1
|
pyrin and HIN domain family, member 1 |
chr6_+_53948328 | 4.08 |
ENST00000370876.2
|
MLIP
|
muscular LMNA-interacting protein |
chr7_-_38339890 | 3.99 |
ENST00000390341.2
|
TRGV10
|
T cell receptor gamma variable 10 (non-functional) |
chr8_-_126963487 | 3.93 |
ENST00000518964.1
|
LINC00861
|
long intergenic non-protein coding RNA 861 |
chrX_+_135730297 | 3.93 |
ENST00000370629.2
|
CD40LG
|
CD40 ligand |
chr3_-_112218378 | 3.92 |
ENST00000334529.5
|
BTLA
|
B and T lymphocyte associated |
chr8_-_126963417 | 3.85 |
ENST00000500989.2
|
LINC00861
|
long intergenic non-protein coding RNA 861 |
chr13_+_32313658 | 3.85 |
ENST00000380314.1
ENST00000298386.2 |
RXFP2
|
relaxin/insulin-like family peptide receptor 2 |
chr13_-_46716969 | 3.80 |
ENST00000435666.2
|
LCP1
|
lymphocyte cytosolic protein 1 (L-plastin) |
chr14_+_22554680 | 3.76 |
ENST00000390451.2
|
TRAV23DV6
|
T cell receptor alpha variable 23/delta variable 6 |
chr16_+_30484021 | 3.76 |
ENST00000358164.5
|
ITGAL
|
integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide) |
chr1_-_160832670 | 3.74 |
ENST00000368032.2
|
CD244
|
CD244 molecule, natural killer cell receptor 2B4 |
chr4_-_70653673 | 3.73 |
ENST00000512870.1
|
SULT1B1
|
sulfotransferase family, cytosolic, 1B, member 1 |
chr7_+_37723336 | 3.73 |
ENST00000450180.1
|
GPR141
|
G protein-coupled receptor 141 |
chr14_+_22675388 | 3.66 |
ENST00000390461.2
|
TRAV34
|
T cell receptor alpha variable 34 |
chr1_-_160832490 | 3.62 |
ENST00000322302.7
ENST00000368033.3 |
CD244
|
CD244 molecule, natural killer cell receptor 2B4 |
chrX_+_135730373 | 3.61 |
ENST00000370628.2
|
CD40LG
|
CD40 ligand |
chr8_-_134114866 | 3.57 |
ENST00000524345.1
|
SLA
|
Src-like-adaptor |
chr14_+_22580233 | 3.56 |
ENST00000390454.2
|
TRAV25
|
T cell receptor alpha variable 25 |
chr7_+_142028105 | 3.56 |
ENST00000390353.2
|
TRBV6-1
|
T cell receptor beta variable 6-1 |
chr19_+_55085248 | 3.56 |
ENST00000391738.3
ENST00000251376.3 ENST00000391737.1 ENST00000396321.2 ENST00000418536.2 ENST00000448689.1 |
LILRA2
LILRB1
|
leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 2 leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 1 |
chr16_+_30483962 | 3.54 |
ENST00000356798.6
|
ITGAL
|
integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide) |
chr7_-_142139783 | 3.47 |
ENST00000390374.3
|
TRBV7-6
|
T cell receptor beta variable 7-6 |
chr16_+_27413483 | 3.45 |
ENST00000337929.3
ENST00000564089.1 |
IL21R
|
interleukin 21 receptor |
chr11_-_2323089 | 3.38 |
ENST00000456145.2
|
C11orf21
|
chromosome 11 open reading frame 21 |
chr19_-_51875894 | 3.38 |
ENST00000600427.1
ENST00000595217.1 ENST00000221978.5 |
NKG7
|
natural killer cell group 7 sequence |
chr7_-_142207004 | 3.38 |
ENST00000426318.2
|
TRBV10-2
|
T cell receptor beta variable 10-2 |
chr16_+_30484054 | 3.36 |
ENST00000564118.1
ENST00000454514.2 ENST00000433423.2 |
ITGAL
|
integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide) |
chr7_-_142511084 | 3.30 |
ENST00000417977.2
|
TRBV30
|
T cell receptor beta variable 30 (gene/pseudogene) |
chr1_-_183538319 | 3.27 |
ENST00000420553.1
ENST00000419402.1 |
NCF2
|
neutrophil cytosolic factor 2 |
chr5_+_35852797 | 3.23 |
ENST00000508941.1
|
IL7R
|
interleukin 7 receptor |
chr7_-_29235063 | 3.22 |
ENST00000437527.1
ENST00000455544.1 |
CPVL
|
carboxypeptidase, vitellogenic-like |
chr1_+_66458072 | 3.21 |
ENST00000423207.2
|
PDE4B
|
phosphodiesterase 4B, cAMP-specific |
chr1_-_159684371 | 3.21 |
ENST00000255030.5
ENST00000437342.1 ENST00000368112.1 ENST00000368111.1 ENST00000368110.1 ENST00000343919.2 |
CRP
|
C-reactive protein, pentraxin-related |
chr19_-_54784353 | 3.19 |
ENST00000391746.1
|
LILRB2
|
leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 2 |
chr13_-_46785977 | 3.18 |
ENST00000442275.1
|
LCP1
|
lymphocyte cytosolic protein 1 (L-plastin) |
chr6_-_108145499 | 3.15 |
ENST00000369020.3
ENST00000369022.2 |
SCML4
|
sex comb on midleg-like 4 (Drosophila) |
chr6_-_24936170 | 3.14 |
ENST00000538035.1
|
FAM65B
|
family with sequence similarity 65, member B |
chr3_-_44465475 | 3.13 |
ENST00000416124.1
|
LINC00694
|
long intergenic non-protein coding RNA 694 |
chr1_-_160832642 | 3.13 |
ENST00000368034.4
|
CD244
|
CD244 molecule, natural killer cell receptor 2B4 |
chr12_-_109027643 | 3.08 |
ENST00000388962.3
ENST00000550948.1 |
SELPLG
|
selectin P ligand |
chr8_-_134114721 | 3.03 |
ENST00000522119.1
ENST00000523610.1 ENST00000521302.1 ENST00000519558.1 ENST00000519747.1 ENST00000517648.1 |
SLA
|
Src-like-adaptor |
chr1_-_161600942 | 2.98 |
ENST00000421702.2
|
FCGR3B
|
Fc fragment of IgG, low affinity IIIb, receptor (CD16b) |
chrX_-_70331298 | 2.97 |
ENST00000456850.2
ENST00000473378.1 ENST00000487883.1 ENST00000374202.2 |
IL2RG
|
interleukin 2 receptor, gamma |
chrX_-_47489244 | 2.97 |
ENST00000469388.1
ENST00000396992.3 ENST00000377005.2 |
CFP
|
complement factor properdin |
chr4_-_74847800 | 2.96 |
ENST00000296029.3
|
PF4
|
platelet factor 4 |
chr14_+_22739823 | 2.93 |
ENST00000390464.2
|
TRAV38-1
|
T cell receptor alpha variable 38-1 |
chr19_-_51875523 | 2.91 |
ENST00000593572.1
ENST00000595157.1 |
NKG7
|
natural killer cell group 7 sequence |
chr12_-_10562356 | 2.90 |
ENST00000309384.1
|
KLRC4
|
killer cell lectin-like receptor subfamily C, member 4 |
chr4_-_48116540 | 2.88 |
ENST00000506073.1
|
TXK
|
TXK tyrosine kinase |
chr1_+_161185032 | 2.87 |
ENST00000367992.3
ENST00000289902.1 |
FCER1G
|
Fc fragment of IgE, high affinity I, receptor for; gamma polypeptide |
chr8_-_133772870 | 2.87 |
ENST00000522334.1
ENST00000519016.1 |
TMEM71
|
transmembrane protein 71 |
chr13_-_99959641 | 2.84 |
ENST00000376414.4
|
GPR183
|
G protein-coupled receptor 183 |
chr19_-_54604083 | 2.83 |
ENST00000391761.1
ENST00000356532.3 ENST00000359649.4 ENST00000358375.4 ENST00000391760.1 ENST00000351806.4 |
OSCAR
|
osteoclast associated, immunoglobulin-like receptor |
chr2_-_87018784 | 2.83 |
ENST00000283635.3
ENST00000538832.1 |
CD8A
|
CD8a molecule |
chr3_-_72150076 | 2.81 |
ENST00000488545.1
ENST00000608654.1 |
LINC00877
|
long intergenic non-protein coding RNA 877 |
chr5_+_112074029 | 2.79 |
ENST00000512211.2
|
APC
|
adenomatous polyposis coli |
chr19_+_14693888 | 2.77 |
ENST00000547437.1
ENST00000397439.2 ENST00000417570.1 |
CLEC17A
|
C-type lectin domain family 17, member A |
chr19_+_51628165 | 2.75 |
ENST00000250360.3
ENST00000440804.3 |
SIGLEC9
|
sialic acid binding Ig-like lectin 9 |
chr7_+_142008340 | 2.74 |
ENST00000390387.3
|
TRBV3-1
|
T cell receptor beta variable 3-1 |
chr14_+_23002427 | 2.72 |
ENST00000390527.1
|
TRAJ10
|
T cell receptor alpha joining 10 |
chr8_+_31497271 | 2.72 |
ENST00000520407.1
|
NRG1
|
neuregulin 1 |
chr14_+_22670455 | 2.72 |
ENST00000390460.1
|
TRAV26-2
|
T cell receptor alpha variable 26-2 |
chr1_-_161600990 | 2.68 |
ENST00000531221.1
|
FCGR3B
|
Fc fragment of IgG, low affinity IIIb, receptor (CD16b) |
chr17_-_47286729 | 2.65 |
ENST00000300406.2
ENST00000511277.1 ENST00000511673.1 |
GNGT2
|
guanine nucleotide binding protein (G protein), gamma transducing activity polypeptide 2 |
chr5_-_169694286 | 2.65 |
ENST00000521416.1
ENST00000520344.1 |
LCP2
|
lymphocyte cytosolic protein 2 (SH2 domain containing leukocyte protein of 76kDa) |
chr7_+_142045246 | 2.64 |
ENST00000390392.3
|
TRBV4-2
|
T cell receptor beta variable 4-2 |
chr7_+_142020496 | 2.63 |
ENST00000390381.3
|
TRBV5-1
|
T cell receptor beta variable 5-1 |
chr2_-_32489922 | 2.63 |
ENST00000402280.1
|
NLRC4
|
NLR family, CARD domain containing 4 |
chr3_+_111260980 | 2.63 |
ENST00000438817.2
|
CD96
|
CD96 molecule |
chr17_-_72527605 | 2.61 |
ENST00000392621.1
ENST00000314401.3 |
CD300LB
|
CD300 molecule-like family member b |
chr4_+_40198527 | 2.61 |
ENST00000381799.5
|
RHOH
|
ras homolog family member H |
chr1_-_207096529 | 2.60 |
ENST00000525793.1
ENST00000529560.1 |
FAIM3
|
Fas apoptotic inhibitory molecule 3 |
chr12_+_9144626 | 2.60 |
ENST00000543895.1
|
KLRG1
|
killer cell lectin-like receptor subfamily G, member 1 |
chr14_-_23877474 | 2.59 |
ENST00000405093.3
|
MYH6
|
myosin, heavy chain 6, cardiac muscle, alpha |
chr4_-_165305086 | 2.59 |
ENST00000507270.1
ENST00000514618.1 ENST00000503008.1 |
MARCH1
|
membrane-associated ring finger (C3HC4) 1, E3 ubiquitin protein ligase |
chr5_-_169725231 | 2.58 |
ENST00000046794.5
|
LCP2
|
lymphocyte cytosolic protein 2 (SH2 domain containing leukocyte protein of 76kDa) |
chr21_+_30503282 | 2.58 |
ENST00000399925.1
|
MAP3K7CL
|
MAP3K7 C-terminal like |
chr6_-_159466136 | 2.57 |
ENST00000367066.3
ENST00000326965.6 |
TAGAP
|
T-cell activation RhoGTPase activating protein |
chr19_+_51645556 | 2.55 |
ENST00000601682.1
ENST00000317643.6 ENST00000305628.7 ENST00000600577.1 |
SIGLEC7
|
sialic acid binding Ig-like lectin 7 |
chr19_+_42300369 | 2.55 |
ENST00000357396.3
ENST00000221999.4 |
CEACAM3
|
carcinoembryonic antigen-related cell adhesion molecule 3 |
chr7_+_142448053 | 2.54 |
ENST00000422143.2
|
TRBV29-1
|
T cell receptor beta variable 29-1 |
chr2_-_179672142 | 2.52 |
ENST00000342992.6
ENST00000360870.5 ENST00000460472.2 ENST00000589042.1 ENST00000591111.1 ENST00000342175.6 ENST00000359218.5 |
TTN
|
titin |
chr11_+_118175132 | 2.51 |
ENST00000361763.4
|
CD3E
|
CD3e molecule, epsilon (CD3-TCR complex) |
chr16_+_30194293 | 2.51 |
ENST00000561815.1
|
CORO1A
|
coronin, actin binding protein, 1A |
chr14_+_23016437 | 2.50 |
ENST00000478163.3
|
TRAC
|
T cell receptor alpha constant |
chr19_-_3801789 | 2.49 |
ENST00000590849.1
ENST00000395045.2 |
MATK
|
megakaryocyte-associated tyrosine kinase |
chr1_-_153363452 | 2.47 |
ENST00000368732.1
ENST00000368733.3 |
S100A8
|
S100 calcium binding protein A8 |
chr10_+_129785574 | 2.47 |
ENST00000430713.2
ENST00000471218.1 |
PTPRE
|
protein tyrosine phosphatase, receptor type, E |
chr12_-_111358372 | 2.47 |
ENST00000548438.1
ENST00000228841.8 |
MYL2
|
myosin, light chain 2, regulatory, cardiac, slow |
chr1_-_161600822 | 2.45 |
ENST00000534776.1
ENST00000540048.1 |
FCGR3B
FCGR3A
|
Fc fragment of IgG, low affinity IIIb, receptor (CD16b) Fc fragment of IgG, low affinity IIIa, receptor (CD16a) |
chr14_-_106471723 | 2.43 |
ENST00000390595.2
|
IGHV1-3
|
immunoglobulin heavy variable 1-3 |
chr6_-_130182410 | 2.42 |
ENST00000368143.1
|
TMEM244
|
transmembrane protein 244 |
chr12_+_8662057 | 2.41 |
ENST00000382064.2
|
CLEC4D
|
C-type lectin domain family 4, member D |
chr6_+_53948221 | 2.40 |
ENST00000460844.2
|
MLIP
|
muscular LMNA-interacting protein |
chr11_-_2323290 | 2.40 |
ENST00000381153.3
|
C11orf21
|
chromosome 11 open reading frame 21 |
chr17_+_16318909 | 2.39 |
ENST00000577397.1
|
TRPV2
|
transient receptor potential cation channel, subfamily V, member 2 |
chr17_+_45810594 | 2.37 |
ENST00000177694.1
|
TBX21
|
T-box 21 |
chr17_-_38020392 | 2.37 |
ENST00000346872.3
ENST00000439167.2 ENST00000377945.3 ENST00000394189.2 ENST00000377944.3 ENST00000377958.2 ENST00000535189.1 ENST00000377952.2 |
IKZF3
|
IKAROS family zinc finger 3 (Aiolos) |
chr10_+_129785536 | 2.36 |
ENST00000419012.2
|
PTPRE
|
protein tyrosine phosphatase, receptor type, E |
chr8_-_134115118 | 2.36 |
ENST00000395352.3
ENST00000338087.5 |
SLA
|
Src-like-adaptor |
chr7_+_142031986 | 2.36 |
ENST00000547918.2
|
TRBV7-1
|
T cell receptor beta variable 7-1 (non-functional) |
chr7_+_80267973 | 2.35 |
ENST00000394788.3
ENST00000447544.2 |
CD36
|
CD36 molecule (thrombospondin receptor) |
chr6_+_31674639 | 2.35 |
ENST00000556581.1
ENST00000375832.4 ENST00000503322.1 |
LY6G6F
MEGT1
|
lymphocyte antigen 6 complex, locus G6F HCG43720, isoform CRA_a; Lymphocyte antigen 6 complex locus protein G6f; Megakaryocyte-enhanced gene transcript 1 protein; Uncharacterized protein |
chr7_-_142169013 | 2.35 |
ENST00000454561.2
|
TRBV5-4
|
T cell receptor beta variable 5-4 |
chr19_+_52264104 | 2.34 |
ENST00000340023.6
|
FPR2
|
formyl peptide receptor 2 |
chr8_+_27184320 | 2.32 |
ENST00000522517.1
|
PTK2B
|
protein tyrosine kinase 2 beta |
chr14_+_22748980 | 2.32 |
ENST00000390465.2
|
TRAV38-2DV8
|
T cell receptor alpha variable 38-2/delta variable 8 |
chr7_-_38389573 | 2.32 |
ENST00000390344.2
|
TRGV5
|
T cell receptor gamma variable 5 |
chr8_-_134114887 | 2.31 |
ENST00000519341.1
|
SLA
|
Src-like-adaptor |
chr1_+_174933899 | 2.31 |
ENST00000367688.3
|
RABGAP1L
|
RAB GTPase activating protein 1-like |
chrX_+_78426469 | 2.30 |
ENST00000276077.1
|
GPR174
|
G protein-coupled receptor 174 |
chr6_-_41122063 | 2.30 |
ENST00000426005.2
ENST00000437044.2 ENST00000373127.4 |
TREML1
|
triggering receptor expressed on myeloid cells-like 1 |
chr19_-_52254050 | 2.30 |
ENST00000600815.1
|
FPR1
|
formyl peptide receptor 1 |
chr17_+_16318850 | 2.30 |
ENST00000338560.7
|
TRPV2
|
transient receptor potential cation channel, subfamily V, member 2 |
chr1_+_159772121 | 2.29 |
ENST00000339348.5
ENST00000392235.3 ENST00000368106.3 |
FCRL6
|
Fc receptor-like 6 |
chr14_+_22471345 | 2.29 |
ENST00000390446.3
|
TRAV18
|
T cell receptor alpha variable 18 |
chr2_-_8464760 | 2.28 |
ENST00000430192.1
|
LINC00299
|
long intergenic non-protein coding RNA 299 |
chr2_+_74229812 | 2.27 |
ENST00000305799.7
|
TET3
|
tet methylcytosine dioxygenase 3 |
chr16_+_30194916 | 2.25 |
ENST00000570045.1
ENST00000565497.1 ENST00000570244.1 |
CORO1A
|
coronin, actin binding protein, 1A |
chr17_-_38020379 | 2.23 |
ENST00000351680.3
ENST00000346243.3 ENST00000350532.3 ENST00000467757.1 ENST00000439016.2 |
IKZF3
|
IKAROS family zinc finger 3 (Aiolos) |
chr6_-_31560729 | 2.22 |
ENST00000340027.5
ENST00000376073.4 ENST00000376072.3 |
NCR3
|
natural cytotoxicity triggering receptor 3 |
chr2_-_87017948 | 2.22 |
ENST00000409781.1
|
CD8A
|
CD8a molecule |
chr7_-_38289173 | 2.21 |
ENST00000436911.2
|
TRGC2
|
T cell receptor gamma constant 2 |
chr14_+_22236722 | 2.21 |
ENST00000390428.3
|
TRAV6
|
T cell receptor alpha variable 6 |
chr9_-_137809718 | 2.21 |
ENST00000371806.3
|
FCN1
|
ficolin (collagen/fibrinogen domain containing) 1 |
chr11_+_60869867 | 2.21 |
ENST00000347785.3
|
CD5
|
CD5 molecule |
chr1_+_153330322 | 2.20 |
ENST00000368738.3
|
S100A9
|
S100 calcium binding protein A9 |
chr5_+_39105358 | 2.20 |
ENST00000593965.1
|
AC008964.1
|
AC008964.1 |
chr22_+_42148515 | 2.20 |
ENST00000540880.1
|
MEI1
|
meiosis inhibitor 1 |
chr14_+_22392209 | 2.20 |
ENST00000390440.2
|
TRAV14DV4
|
T cell receptor alpha variable 14/delta variable 4 |
chr3_-_27763803 | 2.20 |
ENST00000449599.1
|
EOMES
|
eomesodermin |
chr7_+_18330035 | 2.19 |
ENST00000413509.2
|
HDAC9
|
histone deacetylase 9 |
chr14_+_22446680 | 2.19 |
ENST00000390443.3
|
TRAV8-6
|
T cell receptor alpha variable 8-6 |
chr2_-_113594279 | 2.19 |
ENST00000416750.1
ENST00000418817.1 ENST00000263341.2 |
IL1B
|
interleukin 1, beta |
chr19_-_52150053 | 2.17 |
ENST00000599649.1
ENST00000429354.3 ENST00000360844.6 ENST00000222107.4 |
SIGLEC5
SIGLEC14
SIGLEC5
|
SIGLEC5 sialic acid binding Ig-like lectin 14 sialic acid binding Ig-like lectin 5 |
chr11_+_122733011 | 2.16 |
ENST00000533709.1
|
CRTAM
|
cytotoxic and regulatory T cell molecule |
chr21_+_43823983 | 2.15 |
ENST00000291535.6
ENST00000450356.1 ENST00000319294.6 ENST00000398367.1 |
UBASH3A
|
ubiquitin associated and SH3 domain containing A |
chr21_+_30502806 | 2.15 |
ENST00000399928.1
ENST00000399926.1 |
MAP3K7CL
|
MAP3K7 C-terminal like |
chr11_+_12132117 | 2.14 |
ENST00000256194.4
|
MICAL2
|
microtubule associated monooxygenase, calponin and LIM domain containing 2 |
chr1_+_27158505 | 2.14 |
ENST00000534643.1
|
ZDHHC18
|
zinc finger, DHHC-type containing 18 |
chr14_+_22615942 | 2.14 |
ENST00000390457.2
|
TRAV27
|
T cell receptor alpha variable 27 |
chr6_-_24911195 | 2.13 |
ENST00000259698.4
|
FAM65B
|
family with sequence similarity 65, member B |
chr9_-_136004782 | 2.11 |
ENST00000393157.3
|
RALGDS
|
ral guanine nucleotide dissociation stimulator |
chr14_-_106312010 | 2.11 |
ENST00000390556.2
|
IGHD
|
immunoglobulin heavy constant delta |
chr17_-_47286579 | 2.10 |
ENST00000515635.1
|
GNGT2
|
guanine nucleotide binding protein (G protein), gamma transducing activity polypeptide 2 |
chr22_-_30661807 | 2.10 |
ENST00000403389.1
|
OSM
|
oncostatin M |
chr16_+_57702210 | 2.10 |
ENST00000450388.3
|
GPR97
|
G protein-coupled receptor 97 |
chr1_+_158815588 | 2.09 |
ENST00000438394.1
|
MNDA
|
myeloid cell nuclear differentiation antigen |
chrX_+_12885183 | 2.09 |
ENST00000380659.3
|
TLR7
|
toll-like receptor 7 |
chr6_-_113953705 | 2.09 |
ENST00000452675.1
|
RP11-367G18.1
|
RP11-367G18.1 |
chr3_+_111260856 | 2.08 |
ENST00000352690.4
|
CD96
|
CD96 molecule |
chr17_+_44803922 | 2.08 |
ENST00000465370.1
|
NSF
|
N-ethylmaleimide-sensitive factor |
chr4_-_130014532 | 2.08 |
ENST00000506368.1
ENST00000439369.2 ENST00000503215.1 |
SCLT1
|
sodium channel and clathrin linker 1 |
chr6_+_106546808 | 2.08 |
ENST00000369089.3
|
PRDM1
|
PR domain containing 1, with ZNF domain |
chr17_-_7081435 | 2.08 |
ENST00000380920.4
|
ASGR1
|
asialoglycoprotein receptor 1 |
chr3_+_108541545 | 2.08 |
ENST00000295756.6
|
TRAT1
|
T cell receptor associated transmembrane adaptor 1 |
chr10_+_49892904 | 2.07 |
ENST00000360890.2
|
WDFY4
|
WDFY family member 4 |
chr19_-_48547294 | 2.07 |
ENST00000293255.2
|
CABP5
|
calcium binding protein 5 |
chr5_+_54320078 | 2.07 |
ENST00000231009.2
|
GZMK
|
granzyme K (granzyme 3; tryptase II) |
chr1_+_154293584 | 2.06 |
ENST00000324978.3
ENST00000484864.1 |
AQP10
|
aquaporin 10 |
chr11_-_1782625 | 2.06 |
ENST00000438213.1
|
CTSD
|
cathepsin D |
chr8_-_6836156 | 2.06 |
ENST00000382679.2
|
DEFA1
|
defensin, alpha 1 |
chr16_+_5009250 | 2.06 |
ENST00000587469.1
|
SEC14L5
|
SEC14-like 5 (S. cerevisiae) |
chr16_-_55478666 | 2.05 |
ENST00000565307.1
|
RP11-212I21.2
|
RP11-212I21.2 |
chr2_-_87017985 | 2.05 |
ENST00000352580.3
|
CD8A
|
CD8a molecule |
chr7_-_142247606 | 2.04 |
ENST00000390361.3
|
TRBV7-3
|
T cell receptor beta variable 7-3 |
chr14_+_22978168 | 2.04 |
ENST00000390505.1
|
TRAJ32
|
T cell receptor alpha joining 32 |
chr6_+_32407619 | 2.04 |
ENST00000395388.2
ENST00000374982.5 |
HLA-DRA
|
major histocompatibility complex, class II, DR alpha |
chr14_+_22591276 | 2.04 |
ENST00000390455.3
|
TRAV26-1
|
T cell receptor alpha variable 26-1 |
chr7_-_142120321 | 2.03 |
ENST00000390377.1
|
TRBV7-7
|
T cell receptor beta variable 7-7 |
chr16_+_56782118 | 2.03 |
ENST00000566678.1
|
NUP93
|
nucleoporin 93kDa |
chr19_+_35939154 | 2.02 |
ENST00000599180.2
|
FFAR2
|
free fatty acid receptor 2 |
chr3_+_111260954 | 2.02 |
ENST00000283285.5
|
CD96
|
CD96 molecule |
chr11_+_60869980 | 2.02 |
ENST00000544014.1
|
CD5
|
CD5 molecule |
chr11_+_60223312 | 2.02 |
ENST00000532491.1
ENST00000532073.1 ENST00000534668.1 ENST00000528313.1 ENST00000533306.1 |
MS4A1
|
membrane-spanning 4-domains, subfamily A, member 1 |
chr16_+_58033450 | 2.01 |
ENST00000561743.1
|
USB1
|
U6 snRNA biogenesis 1 |
chr10_-_72362515 | 2.00 |
ENST00000373209.2
ENST00000441259.1 |
PRF1
|
perforin 1 (pore forming protein) |
chr6_+_41021027 | 2.00 |
ENST00000244669.2
|
APOBEC2
|
apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 2 |
chr19_-_54804173 | 2.00 |
ENST00000391744.3
ENST00000251390.3 |
LILRA3
|
leukocyte immunoglobulin-like receptor, subfamily A (without TM domain), member 3 |
chr1_-_161519682 | 1.99 |
ENST00000367969.3
ENST00000443193.1 |
FCGR3A
|
Fc fragment of IgG, low affinity IIIa, receptor (CD16a) |
chr17_-_38721711 | 1.99 |
ENST00000578085.1
ENST00000246657.2 |
CCR7
|
chemokine (C-C motif) receptor 7 |
chr15_-_22448819 | 1.99 |
ENST00000604066.1
|
IGHV1OR15-1
|
immunoglobulin heavy variable 1/OR15-1 (non-functional) |
chr1_+_40862501 | 1.98 |
ENST00000539317.1
|
SMAP2
|
small ArfGAP2 |
chrX_+_71353499 | 1.98 |
ENST00000373677.1
|
NHSL2
|
NHS-like 2 |
chr16_-_50715239 | 1.97 |
ENST00000330943.4
ENST00000300590.3 |
SNX20
|
sorting nexin 20 |
chr1_+_159770292 | 1.97 |
ENST00000536257.1
ENST00000321935.6 |
FCRL6
|
Fc receptor-like 6 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.0 | 11.9 | GO:0071613 | granzyme B production(GO:0071613) regulation of granzyme B production(GO:0071661) positive regulation of granzyme B production(GO:0071663) |
2.2 | 6.7 | GO:0002728 | negative regulation of natural killer cell cytokine production(GO:0002728) |
1.6 | 4.7 | GO:0001812 | positive regulation of type I hypersensitivity(GO:0001812) |
1.5 | 4.5 | GO:1990108 | protein linear deubiquitination(GO:1990108) |
1.5 | 5.9 | GO:2001191 | gamma-delta T cell activation involved in immune response(GO:0002290) negative regulation of interferon-beta secretion(GO:0035548) regulation of gamma-delta T cell activation involved in immune response(GO:2001191) positive regulation of gamma-delta T cell activation involved in immune response(GO:2001193) |
1.4 | 7.2 | GO:0032796 | uropod organization(GO:0032796) |
1.4 | 7.1 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
1.4 | 4.2 | GO:0002752 | cell surface pattern recognition receptor signaling pathway(GO:0002752) |
1.4 | 2.7 | GO:0002503 | peptide antigen assembly with MHC class II protein complex(GO:0002503) |
1.3 | 4.0 | GO:2000458 | astrocyte chemotaxis(GO:0035700) regulation of astrocyte chemotaxis(GO:2000458) |
1.3 | 3.9 | GO:0002302 | CD8-positive, alpha-beta T cell differentiation involved in immune response(GO:0002302) |
1.3 | 3.9 | GO:0072616 | interleukin-18 secretion(GO:0072616) |
1.1 | 4.6 | GO:0002774 | Fc receptor mediated inhibitory signaling pathway(GO:0002774) |
1.1 | 3.4 | GO:1990654 | sebum secreting cell proliferation(GO:1990654) |
1.1 | 2.2 | GO:0060559 | positive regulation of vitamin metabolic process(GO:0046136) positive regulation of vitamin D biosynthetic process(GO:0060557) positive regulation of calcidiol 1-monooxygenase activity(GO:0060559) |
1.0 | 3.1 | GO:0002818 | intracellular defense response(GO:0002818) |
1.0 | 2.1 | GO:0035915 | pore formation in membrane of other organism(GO:0035915) |
1.0 | 3.9 | GO:0019417 | sulfur oxidation(GO:0019417) |
1.0 | 3.9 | GO:0002432 | granuloma formation(GO:0002432) |
1.0 | 3.9 | GO:0043376 | regulation of CD8-positive, alpha-beta T cell differentiation(GO:0043376) |
0.9 | 2.8 | GO:0002644 | negative regulation of tolerance induction(GO:0002644) |
0.9 | 2.7 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
0.9 | 2.7 | GO:2000523 | regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
0.9 | 0.9 | GO:2000563 | positive regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000563) |
0.9 | 2.6 | GO:0035606 | peptidyl-cysteine S-trans-nitrosylation(GO:0035606) |
0.9 | 2.6 | GO:0061485 | memory T cell proliferation(GO:0061485) |
0.8 | 0.8 | GO:0072678 | T cell migration(GO:0072678) |
0.8 | 3.4 | GO:0002305 | gamma-delta intraepithelial T cell differentiation(GO:0002304) CD8-positive, gamma-delta intraepithelial T cell differentiation(GO:0002305) |
0.8 | 4.2 | GO:0002925 | positive regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002925) |
0.8 | 0.8 | GO:1903778 | protein localization to vacuolar membrane(GO:1903778) |
0.8 | 9.1 | GO:0070269 | pyroptosis(GO:0070269) |
0.8 | 1.6 | GO:0032829 | regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032829) positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032831) |
0.8 | 2.5 | GO:0055073 | cadmium ion homeostasis(GO:0055073) |
0.8 | 11.2 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
0.8 | 2.4 | GO:0034130 | toll-like receptor 1 signaling pathway(GO:0034130) |
0.8 | 1.6 | GO:0002232 | leukocyte chemotaxis involved in inflammatory response(GO:0002232) |
0.8 | 3.9 | GO:0038043 | interleukin-5-mediated signaling pathway(GO:0038043) |
0.8 | 2.3 | GO:2000471 | regulation of hematopoietic stem cell migration(GO:2000471) positive regulation of hematopoietic stem cell migration(GO:2000473) |
0.8 | 4.6 | GO:0060335 | positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
0.8 | 6.9 | GO:0031022 | nuclear migration along microfilament(GO:0031022) |
0.8 | 2.3 | GO:0044727 | DNA demethylation of male pronucleus(GO:0044727) |
0.8 | 2.3 | GO:0033037 | polysaccharide localization(GO:0033037) |
0.7 | 3.0 | GO:0035408 | histone H3-T6 phosphorylation(GO:0035408) |
0.7 | 2.2 | GO:0060370 | susceptibility to T cell mediated cytotoxicity(GO:0060370) |
0.7 | 2.2 | GO:0040010 | positive regulation of growth rate(GO:0040010) regulation of gastric mucosal blood circulation(GO:1904344) positive regulation of gastric mucosal blood circulation(GO:1904346) gastric mucosal blood circulation(GO:1990768) |
0.7 | 2.2 | GO:0072684 | mitochondrial tRNA 3'-trailer cleavage, endonucleolytic(GO:0072684) |
0.7 | 0.7 | GO:0002513 | tolerance induction to self antigen(GO:0002513) |
0.7 | 5.7 | GO:0048769 | sarcomerogenesis(GO:0048769) |
0.7 | 6.3 | GO:1900625 | regulation of monocyte aggregation(GO:1900623) positive regulation of monocyte aggregation(GO:1900625) |
0.7 | 5.6 | GO:0071918 | urea transmembrane transport(GO:0071918) |
0.7 | 6.3 | GO:0031444 | slow-twitch skeletal muscle fiber contraction(GO:0031444) |
0.7 | 12.5 | GO:0015939 | pantothenate metabolic process(GO:0015939) |
0.7 | 2.8 | GO:0050902 | leukocyte adhesive activation(GO:0050902) |
0.7 | 9.5 | GO:0002517 | T cell tolerance induction(GO:0002517) |
0.7 | 2.7 | GO:0035397 | helper T cell enhancement of adaptive immune response(GO:0035397) |
0.7 | 4.7 | GO:0010387 | COP9 signalosome assembly(GO:0010387) |
0.7 | 4.6 | GO:1903435 | positive regulation of constitutive secretory pathway(GO:1903435) |
0.7 | 6.6 | GO:0038129 | directional guidance of interneurons involved in migration from the subpallium to the cortex(GO:0021840) chemorepulsion involved in interneuron migration from the subpallium to the cortex(GO:0021842) ERBB3 signaling pathway(GO:0038129) |
0.7 | 5.3 | GO:0038195 | urokinase plasminogen activator signaling pathway(GO:0038195) |
0.7 | 2.0 | GO:0002881 | negative regulation of chronic inflammatory response to non-antigenic stimulus(GO:0002881) |
0.6 | 3.2 | GO:0018057 | peptidyl-lysine oxidation(GO:0018057) |
0.6 | 1.9 | GO:0006286 | base-excision repair, base-free sugar-phosphate removal(GO:0006286) |
0.6 | 1.9 | GO:0045554 | TRAIL biosynthetic process(GO:0045553) regulation of TRAIL biosynthetic process(GO:0045554) positive regulation of TRAIL biosynthetic process(GO:0045556) |
0.6 | 5.7 | GO:2000660 | negative regulation of interleukin-1-mediated signaling pathway(GO:2000660) |
0.6 | 1.9 | GO:1902823 | negative regulation of late endosome to lysosome transport(GO:1902823) |
0.6 | 4.3 | GO:0038110 | interleukin-2-mediated signaling pathway(GO:0038110) |
0.6 | 3.6 | GO:0002370 | natural killer cell cytokine production(GO:0002370) regulation of natural killer cell cytokine production(GO:0002727) positive regulation of natural killer cell cytokine production(GO:0002729) positive regulation of Fc receptor mediated stimulatory signaling pathway(GO:0060369) |
0.6 | 3.6 | GO:0033277 | abortive mitotic cell cycle(GO:0033277) |
0.6 | 2.3 | GO:0032764 | negative regulation of mast cell cytokine production(GO:0032764) |
0.6 | 2.8 | GO:0034154 | toll-like receptor 7 signaling pathway(GO:0034154) |
0.6 | 2.3 | GO:0070425 | negative regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070425) negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070433) |
0.6 | 7.9 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
0.6 | 2.2 | GO:0034721 | histone H3-K4 demethylation, trimethyl-H3-K4-specific(GO:0034721) |
0.6 | 6.1 | GO:2000334 | blood microparticle formation(GO:0072564) regulation of blood microparticle formation(GO:2000332) positive regulation of blood microparticle formation(GO:2000334) |
0.6 | 0.6 | GO:0045404 | positive regulation of interleukin-4 biosynthetic process(GO:0045404) |
0.6 | 0.6 | GO:0015804 | neutral amino acid transport(GO:0015804) |
0.5 | 1.6 | GO:0032824 | negative regulation of natural killer cell differentiation(GO:0032824) negative regulation of natural killer cell differentiation involved in immune response(GO:0032827) |
0.5 | 2.2 | GO:0046061 | dATP catabolic process(GO:0046061) |
0.5 | 2.2 | GO:0002857 | positive regulation of natural killer cell mediated immune response to tumor cell(GO:0002857) positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002860) |
0.5 | 2.7 | GO:0052250 | modulation of signal transduction in other organism(GO:0044501) modulation by symbiont of host signal transduction pathway(GO:0052027) modulation of signal transduction in other organism involved in symbiotic interaction(GO:0052250) modulation by symbiont of host I-kappaB kinase/NF-kappaB cascade(GO:0085032) |
0.5 | 1.1 | GO:1903526 | negative regulation of membrane tubulation(GO:1903526) |
0.5 | 2.1 | GO:1903770 | regulation of telomere maintenance via recombination(GO:0032207) negative regulation of telomere maintenance via recombination(GO:0032208) negative regulation of single strand break repair(GO:1903517) negative regulation of beta-galactosidase activity(GO:1903770) telomere single strand break repair(GO:1903823) negative regulation of telomere single strand break repair(GO:1903824) |
0.5 | 0.5 | GO:0044725 | chromatin reprogramming in the zygote(GO:0044725) |
0.5 | 1.6 | GO:0033364 | mast cell secretory granule organization(GO:0033364) |
0.5 | 70.9 | GO:0031295 | T cell costimulation(GO:0031295) |
0.5 | 6.2 | GO:0090204 | protein localization to nuclear pore(GO:0090204) |
0.5 | 7.6 | GO:1901898 | negative regulation of relaxation of cardiac muscle(GO:1901898) |
0.5 | 2.5 | GO:0071409 | cellular response to cycloheximide(GO:0071409) |
0.5 | 1.0 | GO:0032618 | interleukin-15 production(GO:0032618) |
0.5 | 5.0 | GO:1904781 | positive regulation of protein localization to centrosome(GO:1904781) |
0.5 | 2.4 | GO:1904882 | telomerase catalytic core complex assembly(GO:1904868) regulation of telomerase catalytic core complex assembly(GO:1904882) positive regulation of telomerase catalytic core complex assembly(GO:1904884) |
0.5 | 2.4 | GO:0006740 | NADPH regeneration(GO:0006740) |
0.5 | 2.9 | GO:1900147 | Schwann cell migration(GO:0036135) regulation of Schwann cell migration(GO:1900147) |
0.5 | 2.4 | GO:0038155 | interleukin-23-mediated signaling pathway(GO:0038155) |
0.5 | 2.9 | GO:2000537 | regulation of B cell chemotaxis(GO:2000537) positive regulation of B cell chemotaxis(GO:2000538) |
0.5 | 1.4 | GO:0032826 | natural killer cell differentiation involved in immune response(GO:0002325) regulation of natural killer cell differentiation involved in immune response(GO:0032826) regulation of extrathymic T cell differentiation(GO:0033082) |
0.5 | 0.9 | GO:1902567 | negative regulation of eosinophil activation(GO:1902567) |
0.5 | 2.8 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
0.5 | 2.8 | GO:0051970 | negative regulation of transmission of nerve impulse(GO:0051970) |
0.5 | 3.3 | GO:0061737 | leukotriene signaling pathway(GO:0061737) |
0.5 | 5.6 | GO:0048003 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
0.5 | 2.3 | GO:0000117 | regulation of transcription involved in G2/M transition of mitotic cell cycle(GO:0000117) |
0.5 | 8.8 | GO:0002717 | positive regulation of natural killer cell mediated immunity(GO:0002717) |
0.5 | 1.8 | GO:0032972 | regulation of muscle filament sliding speed(GO:0032972) |
0.5 | 1.8 | GO:0032661 | regulation of interleukin-18 production(GO:0032661) |
0.5 | 0.5 | GO:0071677 | positive regulation of mononuclear cell migration(GO:0071677) |
0.5 | 2.3 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
0.5 | 9.1 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
0.5 | 3.6 | GO:0001915 | negative regulation of T cell mediated cytotoxicity(GO:0001915) |
0.4 | 1.3 | GO:0030885 | regulation of myeloid dendritic cell activation(GO:0030885) |
0.4 | 1.8 | GO:0019442 | tryptophan catabolic process to acetyl-CoA(GO:0019442) |
0.4 | 1.3 | GO:1902565 | positive regulation of neutrophil degranulation(GO:0043315) cellular response to gravity(GO:0071258) positive regulation of neutrophil activation(GO:1902565) regulation of transcytosis(GO:1904298) positive regulation of transcytosis(GO:1904300) regulation of maternal process involved in parturition(GO:1904301) positive regulation of maternal process involved in parturition(GO:1904303) response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine(GO:1904316) cellular response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine(GO:1904317) |
0.4 | 4.0 | GO:0051873 | disruption by host of symbiont cells(GO:0051852) killing by host of symbiont cells(GO:0051873) |
0.4 | 0.4 | GO:1903433 | regulation of constitutive secretory pathway(GO:1903433) |
0.4 | 1.3 | GO:0006097 | glyoxylate cycle(GO:0006097) |
0.4 | 3.1 | GO:0003172 | primary heart field specification(GO:0003138) sinoatrial valve development(GO:0003172) sinoatrial valve morphogenesis(GO:0003185) |
0.4 | 1.3 | GO:0032203 | telomere formation via telomerase(GO:0032203) |
0.4 | 2.1 | GO:0010693 | negative regulation of alkaline phosphatase activity(GO:0010693) |
0.4 | 0.4 | GO:0060164 | regulation of timing of neuron differentiation(GO:0060164) |
0.4 | 1.3 | GO:1902948 | regulation of choline O-acetyltransferase activity(GO:1902769) positive regulation of choline O-acetyltransferase activity(GO:1902771) negative regulation of tau-protein kinase activity(GO:1902948) positive regulation of early endosome to recycling endosome transport(GO:1902955) negative regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902960) negative regulation of neurofibrillary tangle assembly(GO:1902997) negative regulation of aspartic-type peptidase activity(GO:1905246) |
0.4 | 1.3 | GO:0061056 | sclerotome development(GO:0061056) |
0.4 | 1.7 | GO:0001878 | response to yeast(GO:0001878) |
0.4 | 0.4 | GO:1904000 | positive regulation of eating behavior(GO:1904000) |
0.4 | 8.0 | GO:2000675 | negative regulation of type B pancreatic cell apoptotic process(GO:2000675) |
0.4 | 2.1 | GO:0010636 | positive regulation of mitochondrial fusion(GO:0010636) |
0.4 | 4.2 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.4 | 0.4 | GO:0043307 | eosinophil activation(GO:0043307) |
0.4 | 3.3 | GO:0006083 | acetate metabolic process(GO:0006083) |
0.4 | 1.2 | GO:0060927 | Purkinje myocyte differentiation(GO:0003168) cardiac pacemaker cell fate commitment(GO:0060927) atrioventricular node cell fate commitment(GO:0060929) |
0.4 | 1.6 | GO:1902963 | regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902962) negative regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902963) |
0.4 | 2.4 | GO:0038112 | interleukin-8-mediated signaling pathway(GO:0038112) |
0.4 | 2.4 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
0.4 | 2.8 | GO:0019557 | histidine catabolic process to glutamate and formamide(GO:0019556) histidine catabolic process to glutamate and formate(GO:0019557) formamide metabolic process(GO:0043606) |
0.4 | 1.2 | GO:0045925 | positive regulation of female receptivity(GO:0045925) |
0.4 | 8.7 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
0.4 | 2.0 | GO:2000568 | memory T cell activation(GO:0035709) regulation of memory T cell activation(GO:2000567) positive regulation of memory T cell activation(GO:2000568) |
0.4 | 0.8 | GO:0032621 | interleukin-18 production(GO:0032621) |
0.4 | 0.8 | GO:0014040 | positive regulation of Schwann cell differentiation(GO:0014040) |
0.4 | 1.6 | GO:1904978 | regulation of endosome organization(GO:1904978) |
0.4 | 2.3 | GO:0006436 | tryptophanyl-tRNA aminoacylation(GO:0006436) |
0.4 | 2.3 | GO:2001153 | regulation of renal water transport(GO:2001151) positive regulation of renal water transport(GO:2001153) |
0.4 | 0.8 | GO:0006788 | heme oxidation(GO:0006788) |
0.4 | 1.1 | GO:0098939 | dendritic transport of mitochondrion(GO:0098939) anterograde dendritic transport of mitochondrion(GO:0098972) |
0.4 | 1.1 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
0.4 | 0.8 | GO:1900365 | positive regulation of mRNA polyadenylation(GO:1900365) |
0.4 | 0.4 | GO:2001180 | negative regulation of interleukin-10 secretion(GO:2001180) |
0.4 | 2.3 | GO:0061034 | olfactory bulb mitral cell layer development(GO:0061034) |
0.4 | 3.0 | GO:0070885 | negative regulation of calcineurin-NFAT signaling cascade(GO:0070885) |
0.4 | 1.5 | GO:0046338 | phosphatidylethanolamine catabolic process(GO:0046338) |
0.4 | 0.4 | GO:0002645 | positive regulation of tolerance induction(GO:0002645) |
0.4 | 2.2 | GO:0036493 | positive regulation of translation in response to endoplasmic reticulum stress(GO:0036493) |
0.4 | 1.1 | GO:0002372 | myeloid dendritic cell cytokine production(GO:0002372) |
0.4 | 1.8 | GO:0046668 | regulation of retinal cell programmed cell death(GO:0046668) |
0.4 | 2.2 | GO:2000402 | negative regulation of lymphocyte migration(GO:2000402) |
0.4 | 1.1 | GO:0048250 | mitochondrial iron ion transport(GO:0048250) |
0.4 | 1.8 | GO:2000638 | regulation of SREBP signaling pathway(GO:2000638) negative regulation of SREBP signaling pathway(GO:2000639) |
0.4 | 1.8 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
0.4 | 1.4 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
0.4 | 1.4 | GO:0015785 | UDP-galactose transport(GO:0015785) UDP-galactose transmembrane transport(GO:0072334) |
0.4 | 0.4 | GO:0031627 | telomeric loop formation(GO:0031627) |
0.4 | 3.2 | GO:0090521 | glomerular visceral epithelial cell migration(GO:0090521) |
0.4 | 3.9 | GO:0018377 | protein myristoylation(GO:0018377) |
0.4 | 1.4 | GO:0060392 | negative regulation of SMAD protein import into nucleus(GO:0060392) |
0.4 | 1.1 | GO:1901076 | positive regulation of engulfment of apoptotic cell(GO:1901076) |
0.4 | 6.7 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
0.4 | 1.4 | GO:0048200 | COPI-coated vesicle budding(GO:0035964) Golgi transport vesicle coating(GO:0048200) COPI coating of Golgi vesicle(GO:0048205) |
0.4 | 3.9 | GO:0035897 | proteolysis in other organism(GO:0035897) |
0.3 | 1.0 | GO:0071901 | negative regulation of protein serine/threonine kinase activity(GO:0071901) |
0.3 | 2.4 | GO:0030200 | heparan sulfate proteoglycan catabolic process(GO:0030200) |
0.3 | 1.7 | GO:0045409 | negative regulation of interleukin-6 biosynthetic process(GO:0045409) |
0.3 | 3.4 | GO:0070560 | protein secretion by platelet(GO:0070560) |
0.3 | 0.3 | GO:0060460 | left lung development(GO:0060459) left lung morphogenesis(GO:0060460) |
0.3 | 1.0 | GO:0090022 | regulation of neutrophil chemotaxis(GO:0090022) |
0.3 | 0.3 | GO:0051788 | response to misfolded protein(GO:0051788) |
0.3 | 1.7 | GO:0007525 | somatic muscle development(GO:0007525) |
0.3 | 1.7 | GO:0014835 | myoblast differentiation involved in skeletal muscle regeneration(GO:0014835) positive regulation of interleukin-12 secretion(GO:2001184) |
0.3 | 1.7 | GO:0015788 | UDP-N-acetylglucosamine transport(GO:0015788) UDP-N-acetylglucosamine transmembrane transport(GO:1990569) |
0.3 | 2.6 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.3 | 4.0 | GO:0002191 | cap-dependent translational initiation(GO:0002191) |
0.3 | 0.7 | GO:0045348 | positive regulation of MHC class II biosynthetic process(GO:0045348) |
0.3 | 3.6 | GO:0032264 | IMP salvage(GO:0032264) |
0.3 | 0.3 | GO:0061009 | common bile duct development(GO:0061009) |
0.3 | 2.0 | GO:0033632 | regulation of cell-cell adhesion mediated by integrin(GO:0033632) |
0.3 | 4.6 | GO:0001771 | immunological synapse formation(GO:0001771) |
0.3 | 0.7 | GO:0045824 | negative regulation of innate immune response(GO:0045824) |
0.3 | 1.0 | GO:0048597 | B cell negative selection(GO:0002352) post-embryonic camera-type eye morphogenesis(GO:0048597) |
0.3 | 1.3 | GO:0045591 | positive regulation of regulatory T cell differentiation(GO:0045591) |
0.3 | 3.2 | GO:0009972 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
0.3 | 0.6 | GO:0002476 | antigen processing and presentation of endogenous peptide antigen via MHC class Ib(GO:0002476) |
0.3 | 1.6 | GO:0002378 | immunoglobulin biosynthetic process(GO:0002378) |
0.3 | 2.2 | GO:0071461 | cellular response to redox state(GO:0071461) |
0.3 | 0.9 | GO:0002581 | negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002581) |
0.3 | 1.3 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
0.3 | 1.3 | GO:0051902 | negative regulation of mitochondrial depolarization(GO:0051902) |
0.3 | 1.6 | GO:0000738 | DNA catabolic process, exonucleolytic(GO:0000738) |
0.3 | 0.9 | GO:0043380 | regulation of memory T cell differentiation(GO:0043380) |
0.3 | 3.1 | GO:0048102 | autophagic cell death(GO:0048102) |
0.3 | 2.5 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.3 | 4.6 | GO:0043402 | glucocorticoid mediated signaling pathway(GO:0043402) |
0.3 | 0.9 | GO:0046168 | glycerol-3-phosphate catabolic process(GO:0046168) |
0.3 | 3.3 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
0.3 | 0.3 | GO:0051771 | negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
0.3 | 0.9 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
0.3 | 1.5 | GO:0002074 | extraocular skeletal muscle development(GO:0002074) |
0.3 | 0.9 | GO:2000616 | negative regulation of histone H3-K9 acetylation(GO:2000616) |
0.3 | 0.9 | GO:0043091 | L-arginine import(GO:0043091) arginine import(GO:0090467) |
0.3 | 2.4 | GO:2000158 | positive regulation of ubiquitin-specific protease activity(GO:2000158) |
0.3 | 0.9 | GO:0003032 | detection of oxygen(GO:0003032) |
0.3 | 1.2 | GO:0015910 | peroxisomal long-chain fatty acid import(GO:0015910) |
0.3 | 0.9 | GO:0003245 | cardiac muscle tissue growth involved in heart morphogenesis(GO:0003245) |
0.3 | 0.9 | GO:0046356 | acetyl-CoA catabolic process(GO:0046356) |
0.3 | 1.2 | GO:0006844 | acyl carnitine transport(GO:0006844) acyl carnitine transmembrane transport(GO:1902616) |
0.3 | 5.2 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
0.3 | 2.9 | GO:0072540 | T-helper 17 cell lineage commitment(GO:0072540) |
0.3 | 0.9 | GO:0042761 | very long-chain fatty acid biosynthetic process(GO:0042761) |
0.3 | 1.2 | GO:0036289 | peptidyl-serine autophosphorylation(GO:0036289) |
0.3 | 1.2 | GO:0006218 | uridine catabolic process(GO:0006218) |
0.3 | 0.6 | GO:0046005 | positive regulation of circadian sleep/wake cycle, REM sleep(GO:0046005) |
0.3 | 0.9 | GO:0051685 | maintenance of ER location(GO:0051685) |
0.3 | 0.6 | GO:0046102 | inosine metabolic process(GO:0046102) |
0.3 | 2.6 | GO:1902748 | positive regulation of lens fiber cell differentiation(GO:1902748) |
0.3 | 0.9 | GO:0072737 | response to diamide(GO:0072737) cellular response to diamide(GO:0072738) |
0.3 | 1.7 | GO:0051541 | elastin metabolic process(GO:0051541) |
0.3 | 2.5 | GO:0008582 | regulation of synaptic growth at neuromuscular junction(GO:0008582) |
0.3 | 4.2 | GO:0090023 | positive regulation of neutrophil chemotaxis(GO:0090023) |
0.3 | 3.4 | GO:0030889 | negative regulation of B cell proliferation(GO:0030889) |
0.3 | 0.8 | GO:0032516 | positive regulation of phosphoprotein phosphatase activity(GO:0032516) |
0.3 | 2.2 | GO:1902856 | negative regulation of nonmotile primary cilium assembly(GO:1902856) |
0.3 | 1.4 | GO:0060741 | prostate gland stromal morphogenesis(GO:0060741) |
0.3 | 0.3 | GO:0045410 | positive regulation of interleukin-6 biosynthetic process(GO:0045410) |
0.3 | 0.8 | GO:0080121 | coenzyme A transport(GO:0015880) coenzyme A transmembrane transport(GO:0035349) adenosine 3',5'-bisphosphate transmembrane transport(GO:0071106) AMP transport(GO:0080121) |
0.3 | 1.4 | GO:1904685 | positive regulation of metalloendopeptidase activity(GO:1904685) |
0.3 | 0.6 | GO:0002904 | positive regulation of B cell apoptotic process(GO:0002904) |
0.3 | 1.9 | GO:0016098 | monoterpenoid metabolic process(GO:0016098) |
0.3 | 4.1 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
0.3 | 2.2 | GO:0006623 | protein targeting to lysosome(GO:0006622) protein targeting to vacuole(GO:0006623) |
0.3 | 0.8 | GO:0031587 | positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031587) |
0.3 | 0.5 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
0.3 | 0.8 | GO:2000407 | CD8-positive, alpha-beta T cell extravasation(GO:0035697) CD8-positive, alpha-beta cytotoxic T cell extravasation(GO:0035698) positive regulation of necroptotic process(GO:0060545) regulation of T cell extravasation(GO:2000407) regulation of CD8-positive, alpha-beta T cell extravasation(GO:2000449) regulation of CD8-positive, alpha-beta cytotoxic T cell extravasation(GO:2000452) |
0.3 | 0.5 | GO:1903436 | regulation of cytokinetic process(GO:0032954) regulation of mitotic cytokinetic process(GO:1903436) positive regulation of mitotic cytokinetic process(GO:1903438) positive regulation of mitotic cytokinesis(GO:1903490) |
0.3 | 0.8 | GO:2000342 | negative regulation of chemokine (C-X-C motif) ligand 2 production(GO:2000342) |
0.3 | 0.5 | GO:0015840 | urea transport(GO:0015840) |
0.3 | 0.3 | GO:0001780 | neutrophil homeostasis(GO:0001780) |
0.3 | 0.3 | GO:0060734 | regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:0060734) |
0.3 | 3.5 | GO:0044351 | macropinocytosis(GO:0044351) |
0.3 | 0.8 | GO:0034727 | lysosomal microautophagy(GO:0016237) piecemeal microautophagy of nucleus(GO:0034727) suppression by virus of host autophagy(GO:0039521) |
0.3 | 1.3 | GO:0090370 | negative regulation of cholesterol efflux(GO:0090370) |
0.3 | 1.0 | GO:0090410 | malonate catabolic process(GO:0090410) |
0.3 | 5.0 | GO:0043306 | positive regulation of mast cell activation(GO:0033005) positive regulation of mast cell activation involved in immune response(GO:0033008) positive regulation of mast cell degranulation(GO:0043306) |
0.3 | 2.3 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
0.3 | 1.3 | GO:0033128 | negative regulation of histone phosphorylation(GO:0033128) |
0.3 | 0.8 | GO:0071109 | superior temporal gyrus development(GO:0071109) |
0.3 | 2.9 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.3 | 1.6 | GO:1902045 | negative regulation of Fas signaling pathway(GO:1902045) |
0.3 | 2.1 | GO:0097680 | double-strand break repair via classical nonhomologous end joining(GO:0097680) |
0.3 | 1.0 | GO:0010430 | fatty acid omega-oxidation(GO:0010430) |
0.3 | 0.8 | GO:0045083 | negative regulation of interleukin-12 biosynthetic process(GO:0045083) |
0.3 | 0.8 | GO:0061534 | gamma-aminobutyric acid secretion, neurotransmission(GO:0061534) |
0.3 | 1.0 | GO:0003363 | lamellipodium assembly involved in ameboidal cell migration(GO:0003363) extension of a leading process involved in cell motility in cerebral cortex radial glia guided migration(GO:0021816) |
0.3 | 1.5 | GO:0043271 | negative regulation of ion transport(GO:0043271) |
0.3 | 0.3 | GO:0071218 | cellular response to misfolded protein(GO:0071218) |
0.3 | 3.8 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
0.3 | 1.0 | GO:0006480 | N-terminal protein amino acid methylation(GO:0006480) |
0.3 | 0.8 | GO:0002384 | hepatic immune response(GO:0002384) |
0.3 | 0.3 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
0.3 | 0.8 | GO:0006711 | estrogen catabolic process(GO:0006711) |
0.3 | 0.8 | GO:1990637 | response to prolactin(GO:1990637) |
0.3 | 1.0 | GO:0002625 | regulation of T cell antigen processing and presentation(GO:0002625) |
0.3 | 0.8 | GO:0071930 | negative regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071930) |
0.2 | 3.0 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
0.2 | 1.7 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.2 | 0.7 | GO:0036060 | filtration diaphragm assembly(GO:0036058) slit diaphragm assembly(GO:0036060) |
0.2 | 0.7 | GO:1901143 | insulin catabolic process(GO:1901143) |
0.2 | 1.2 | GO:0000720 | pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) |
0.2 | 0.7 | GO:1904211 | membrane protein proteolysis involved in retrograde protein transport, ER to cytosol(GO:1904211) |
0.2 | 1.0 | GO:0035482 | gastric motility(GO:0035482) gastric emptying(GO:0035483) |
0.2 | 10.1 | GO:0035590 | purinergic nucleotide receptor signaling pathway(GO:0035590) |
0.2 | 1.0 | GO:0006428 | isoleucyl-tRNA aminoacylation(GO:0006428) |
0.2 | 0.7 | GO:2001045 | negative regulation of integrin-mediated signaling pathway(GO:2001045) |
0.2 | 0.5 | GO:0045994 | positive regulation of translational initiation by iron(GO:0045994) |
0.2 | 0.7 | GO:0032753 | positive regulation of interleukin-4 production(GO:0032753) |
0.2 | 17.2 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
0.2 | 1.7 | GO:0019075 | virus maturation(GO:0019075) |
0.2 | 0.5 | GO:0001953 | negative regulation of cell-matrix adhesion(GO:0001953) |
0.2 | 1.0 | GO:0030035 | microspike assembly(GO:0030035) |
0.2 | 0.5 | GO:0019915 | lipid storage(GO:0019915) |
0.2 | 0.7 | GO:0036333 | hepatocyte homeostasis(GO:0036333) response to tetrachloromethane(GO:1904772) |
0.2 | 0.7 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
0.2 | 0.5 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.2 | 1.4 | GO:0010816 | substance P catabolic process(GO:0010814) calcitonin catabolic process(GO:0010816) endothelin maturation(GO:0034959) |
0.2 | 0.9 | GO:0009236 | cobalamin biosynthetic process(GO:0009236) |
0.2 | 0.9 | GO:1902530 | regulation of protein linear polyubiquitination(GO:1902528) positive regulation of protein linear polyubiquitination(GO:1902530) |
0.2 | 0.5 | GO:2000742 | anterior head development(GO:0097065) regulation of anterior head development(GO:2000742) positive regulation of anterior head development(GO:2000744) |
0.2 | 3.8 | GO:1901844 | regulation of cell communication by electrical coupling involved in cardiac conduction(GO:1901844) |
0.2 | 1.9 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
0.2 | 0.5 | GO:0055003 | cardiac myofibril assembly(GO:0055003) |
0.2 | 1.6 | GO:0010572 | positive regulation of platelet activation(GO:0010572) |
0.2 | 0.5 | GO:2000296 | negative regulation of hydrogen peroxide catabolic process(GO:2000296) |
0.2 | 0.7 | GO:0033031 | positive regulation of neutrophil apoptotic process(GO:0033031) |
0.2 | 1.2 | GO:0044208 | 'de novo' AMP biosynthetic process(GO:0044208) |
0.2 | 0.5 | GO:0002767 | immune response-inhibiting cell surface receptor signaling pathway(GO:0002767) |
0.2 | 1.6 | GO:0032227 | negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
0.2 | 3.2 | GO:0061158 | 3'-UTR-mediated mRNA destabilization(GO:0061158) |
0.2 | 1.8 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.2 | 0.2 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
0.2 | 0.9 | GO:0070895 | transposon integration(GO:0070893) regulation of transposon integration(GO:0070894) negative regulation of transposon integration(GO:0070895) |
0.2 | 0.7 | GO:0098884 | postsynaptic neurotransmitter receptor internalization(GO:0098884) |
0.2 | 2.0 | GO:1901341 | activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
0.2 | 1.4 | GO:0032625 | interleukin-21 production(GO:0032625) interleukin-21 secretion(GO:0072619) |
0.2 | 2.3 | GO:1902563 | regulation of neutrophil activation(GO:1902563) |
0.2 | 1.1 | GO:0030581 | intracellular transport of viral protein in host cell(GO:0019060) symbiont intracellular protein transport in host(GO:0030581) intracellular protein transport in other organism involved in symbiotic interaction(GO:0051708) |
0.2 | 0.7 | GO:0001544 | initiation of primordial ovarian follicle growth(GO:0001544) |
0.2 | 0.4 | GO:0071484 | cellular response to light intensity(GO:0071484) |
0.2 | 40.2 | GO:0038094 | Fc-gamma receptor signaling pathway(GO:0038094) |
0.2 | 0.7 | GO:1903033 | regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) positive regulation of microtubule binding(GO:1904528) |
0.2 | 3.1 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
0.2 | 2.2 | GO:0090091 | positive regulation of extracellular matrix disassembly(GO:0090091) |
0.2 | 2.0 | GO:0035494 | SNARE complex disassembly(GO:0035494) |
0.2 | 1.8 | GO:2001199 | negative regulation of dendritic cell differentiation(GO:2001199) |
0.2 | 2.9 | GO:0060059 | embryonic retina morphogenesis in camera-type eye(GO:0060059) |
0.2 | 2.4 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.2 | 0.9 | GO:1905205 | positive regulation of connective tissue replacement(GO:1905205) |
0.2 | 2.0 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
0.2 | 0.4 | GO:0019933 | cAMP-mediated signaling(GO:0019933) |
0.2 | 0.7 | GO:1904897 | regulation of hepatic stellate cell proliferation(GO:1904897) positive regulation of hepatic stellate cell proliferation(GO:1904899) hepatic stellate cell proliferation(GO:1990922) |
0.2 | 4.1 | GO:0002335 | mature B cell differentiation(GO:0002335) |
0.2 | 2.4 | GO:0048304 | positive regulation of isotype switching to IgG isotypes(GO:0048304) |
0.2 | 0.9 | GO:0051490 | negative regulation of filopodium assembly(GO:0051490) |
0.2 | 1.7 | GO:1901297 | positive regulation of ephrin receptor signaling pathway(GO:1901189) positive regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment(GO:1901297) positive regulation of canonical Wnt signaling pathway involved in heart development(GO:1905068) |
0.2 | 0.4 | GO:1904674 | positive regulation of somatic stem cell population maintenance(GO:1904674) |
0.2 | 0.6 | GO:0036451 | cap mRNA methylation(GO:0036451) |
0.2 | 1.3 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
0.2 | 1.7 | GO:0072656 | maintenance of protein location in mitochondrion(GO:0072656) |
0.2 | 0.6 | GO:0046521 | sphingoid catabolic process(GO:0046521) |
0.2 | 2.8 | GO:0032930 | positive regulation of superoxide anion generation(GO:0032930) |
0.2 | 1.1 | GO:0008204 | ergosterol biosynthetic process(GO:0006696) ergosterol metabolic process(GO:0008204) |
0.2 | 1.7 | GO:1902237 | positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902237) |
0.2 | 0.9 | GO:0018101 | protein citrullination(GO:0018101) histone citrullination(GO:0036414) |
0.2 | 10.2 | GO:0002755 | MyD88-dependent toll-like receptor signaling pathway(GO:0002755) |
0.2 | 1.3 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
0.2 | 1.3 | GO:0006990 | positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) |
0.2 | 4.7 | GO:0043485 | endosome to melanosome transport(GO:0035646) endosome to pigment granule transport(GO:0043485) pigment granule maturation(GO:0048757) |
0.2 | 0.2 | GO:0072387 | flavin adenine dinucleotide metabolic process(GO:0072387) |
0.2 | 0.4 | GO:0035359 | negative regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035359) |
0.2 | 0.8 | GO:0006238 | CMP salvage(GO:0006238) CMP biosynthetic process(GO:0009224) CMP metabolic process(GO:0046035) |
0.2 | 4.6 | GO:0071397 | cellular response to cholesterol(GO:0071397) |
0.2 | 0.4 | GO:0044111 | development involved in symbiotic interaction(GO:0044111) |
0.2 | 1.5 | GO:0061767 | negative regulation of lung blood pressure(GO:0061767) |
0.2 | 1.3 | GO:0072752 | cellular response to rapamycin(GO:0072752) |
0.2 | 0.4 | GO:0033029 | neutrophil apoptotic process(GO:0001781) regulation of neutrophil apoptotic process(GO:0033029) |
0.2 | 1.5 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
0.2 | 1.9 | GO:0006772 | thiamine metabolic process(GO:0006772) |
0.2 | 3.1 | GO:0060155 | platelet dense granule organization(GO:0060155) |
0.2 | 0.8 | GO:1902361 | mitochondrial pyruvate transport(GO:0006850) mitochondrial pyruvate transmembrane transport(GO:1902361) |
0.2 | 1.2 | GO:0071386 | cellular response to corticosterone stimulus(GO:0071386) |
0.2 | 0.8 | GO:1901475 | pyruvate transport(GO:0006848) pyruvate transmembrane transport(GO:1901475) |
0.2 | 4.7 | GO:0045730 | respiratory burst(GO:0045730) |
0.2 | 1.0 | GO:0052148 | modulation by virus of host molecular function(GO:0039506) suppression by virus of host molecular function(GO:0039507) suppression by virus of host catalytic activity(GO:0039513) modulation by virus of host catalytic activity(GO:0039516) suppression by virus of host cysteine-type endopeptidase activity involved in apoptotic process(GO:0039650) negative regulation by symbiont of host catalytic activity(GO:0052053) negative regulation by symbiont of host molecular function(GO:0052056) modulation by symbiont of host catalytic activity(GO:0052148) |
0.2 | 0.4 | GO:0032700 | negative regulation of interleukin-17 production(GO:0032700) |
0.2 | 4.9 | GO:0045577 | regulation of B cell differentiation(GO:0045577) |
0.2 | 4.1 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
0.2 | 2.0 | GO:0001866 | NK T cell proliferation(GO:0001866) |
0.2 | 0.6 | GO:1901856 | negative regulation of cellular respiration(GO:1901856) |
0.2 | 0.6 | GO:0070175 | positive regulation of enamel mineralization(GO:0070175) |
0.2 | 0.8 | GO:0036228 | protein targeting to nuclear inner membrane(GO:0036228) |
0.2 | 0.8 | GO:1904996 | positive regulation of leukocyte adhesion to vascular endothelial cell(GO:1904996) |
0.2 | 3.2 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
0.2 | 0.6 | GO:0061582 | colon epithelial cell migration(GO:0061580) intestinal epithelial cell migration(GO:0061582) |
0.2 | 0.6 | GO:1904784 | NLRP1 inflammasome complex assembly(GO:1904784) |
0.2 | 0.6 | GO:1904924 | negative regulation of mitophagy in response to mitochondrial depolarization(GO:1904924) |
0.2 | 2.0 | GO:0090527 | actin filament reorganization(GO:0090527) |
0.2 | 0.8 | GO:0002483 | antigen processing and presentation of endogenous peptide antigen(GO:0002483) antigen processing and presentation of endogenous peptide antigen via MHC class I(GO:0019885) |
0.2 | 0.2 | GO:0005997 | xylulose metabolic process(GO:0005997) |
0.2 | 0.6 | GO:0051097 | negative regulation of helicase activity(GO:0051097) oligodendrocyte apoptotic process(GO:0097252) |
0.2 | 1.6 | GO:0002480 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent(GO:0002480) |
0.2 | 2.4 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
0.2 | 1.4 | GO:0052204 | modulation of molecular function in other organism(GO:0044359) negative regulation of molecular function in other organism(GO:0044362) negative regulation of molecular function in other organism involved in symbiotic interaction(GO:0052204) modulation of molecular function in other organism involved in symbiotic interaction(GO:0052205) modification by host of symbiont molecular function(GO:0052428) |
0.2 | 1.4 | GO:0006642 | triglyceride mobilization(GO:0006642) |
0.2 | 2.8 | GO:0010763 | positive regulation of fibroblast migration(GO:0010763) |
0.2 | 0.6 | GO:0061386 | closure of optic fissure(GO:0061386) |
0.2 | 1.6 | GO:0071494 | cellular response to UV-C(GO:0071494) |
0.2 | 2.0 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
0.2 | 0.8 | GO:0006127 | glycerophosphate shuttle(GO:0006127) |
0.2 | 0.6 | GO:0034402 | recruitment of 3'-end processing factors to RNA polymerase II holoenzyme complex(GO:0034402) |
0.2 | 1.4 | GO:0090063 | positive regulation of microtubule nucleation(GO:0090063) |
0.2 | 5.5 | GO:0034310 | primary alcohol catabolic process(GO:0034310) |
0.2 | 0.8 | GO:0016267 | O-glycan processing, core 1(GO:0016267) |
0.2 | 0.6 | GO:1904428 | negative regulation of tubulin deacetylation(GO:1904428) |
0.2 | 1.0 | GO:0001306 | age-dependent response to oxidative stress(GO:0001306) age-dependent response to reactive oxygen species(GO:0001315) regulation of systemic arterial blood pressure by acetylcholine(GO:0003068) vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure(GO:0003069) regulation of systemic arterial blood pressure by neurotransmitter(GO:0003070) age-dependent general metabolic decline(GO:0007571) |
0.2 | 1.2 | GO:0071550 | death-inducing signaling complex assembly(GO:0071550) |
0.2 | 5.6 | GO:0030101 | natural killer cell activation(GO:0030101) |
0.2 | 2.5 | GO:0055009 | atrial cardiac muscle tissue development(GO:0003228) atrial cardiac muscle tissue morphogenesis(GO:0055009) |
0.2 | 2.7 | GO:0006449 | regulation of translational termination(GO:0006449) |
0.2 | 2.5 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.2 | 2.1 | GO:0035583 | sequestering of TGFbeta in extracellular matrix(GO:0035583) |
0.2 | 0.8 | GO:1903898 | negative regulation of PERK-mediated unfolded protein response(GO:1903898) |
0.2 | 1.9 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.2 | 0.6 | GO:0060304 | regulation of phosphatidylinositol dephosphorylation(GO:0060304) |
0.2 | 0.2 | GO:0048294 | negative regulation of isotype switching to IgE isotypes(GO:0048294) |
0.2 | 14.3 | GO:0038083 | peptidyl-tyrosine autophosphorylation(GO:0038083) |
0.2 | 0.6 | GO:0019082 | viral protein processing(GO:0019082) negative regulation of low-density lipoprotein particle receptor catabolic process(GO:0032804) regulation of nerve growth factor production(GO:0032903) negative regulation of nerve growth factor production(GO:0032904) dibasic protein processing(GO:0090472) |
0.2 | 1.1 | GO:0021993 | initiation of neural tube closure(GO:0021993) |
0.2 | 1.5 | GO:1902261 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) |
0.2 | 2.4 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
0.2 | 2.0 | GO:0007249 | I-kappaB kinase/NF-kappaB signaling(GO:0007249) |
0.2 | 0.4 | GO:0038156 | interleukin-3-mediated signaling pathway(GO:0038156) |
0.2 | 2.0 | GO:0038145 | macrophage colony-stimulating factor signaling pathway(GO:0038145) |
0.2 | 0.4 | GO:0036295 | cellular response to increased oxygen levels(GO:0036295) |
0.2 | 0.9 | GO:2000312 | regulation of kainate selective glutamate receptor activity(GO:2000312) |
0.2 | 0.9 | GO:0089700 | protein kinase D signaling(GO:0089700) |
0.2 | 1.1 | GO:0035743 | CD4-positive, alpha-beta T cell cytokine production(GO:0035743) T-helper 2 cell cytokine production(GO:0035745) |
0.2 | 0.7 | GO:1903060 | regulation of N-terminal protein palmitoylation(GO:0060254) negative regulation of N-terminal protein palmitoylation(GO:0060262) negative regulation of protein lipidation(GO:1903060) |
0.2 | 0.5 | GO:0044179 | hemolysis by symbiont of host erythrocytes(GO:0019836) hemolysis in other organism(GO:0044179) hemolysis in other organism involved in symbiotic interaction(GO:0052331) |